港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

482.357

-14.363-2.89%

漲家數：12

跌家數：18

平家數：3

市盈率：- -

高：497.296

開：496.590

低：481.390

收：496.720

成交量：7,829.28萬

成交額：21.60億

市值：3,067.82億

流通市值：2,726.46億

資料載入中...

總覽新聞資訊

CRO板塊強勢走高！多家CRO上市公司解密業務近況

微博财经-财道工作室

智通港股解盤 | 美國放緩AI另有玄機 WCLC大會再度催化創新藥

心瑋醫療-B(06609)授出56萬份股份獎勵

康寧傑瑞製藥-B(09966)9月14日耗資約79.63萬港元回購9.9萬股

董事會主席兼首席執行官倪昕增持億騰嘉和(06998)20萬股每股作價約1.74港元

智通财经网

縮量震盪下，創新藥逆市爆發，中證銀行指數上探年內新高！光模塊回調，高「光」ETF獲資金逢低關注

董事會主席吳以芳增持雲頂新耀(01952)8000股每股作價26.9港元

智通财经网

德琪醫藥-B(06996.HK)因受限制股份單位獲歸屬而發行合共1009萬股

董事長兼總裁吳豫生增持同源康醫藥-B(02410)17萬股每股作價約2.7港元

智通财经网

ETF日報：短期看在A股整體市場動能偏弱、熱點輪動加快的環境下，前期調整的創新藥、CXO板塊擁有一定性價比

康哲藥業(00867)：創新藥高選擇性TYK2抑制劑CMS-D001 獲得系統性紅斑狼瘡適應症藥物臨床試驗批准通知書

國家醫保局公布價格招採信用評價「特別嚴重失信」和「嚴重失信」名單

恒瑞創新藥凝血因子XI單抗SHR-2004注射液用於擇期膝關節置換手術後成年患者靜脈血栓預防的上市申請獲受理

北水動向|北水成交淨買入44.71億北水逢低加倉AI硬件股全天搶籌智譜(02513)超12億港元

歸創通橋(02190)9月14日斥資113.14萬港元回購5.5萬股

市場縮量調整，三大指數震盪回調，醫藥銀行集體護盤| 華寶基金3A日報（2026.9.14）

ETF日報(09.14)丨WCLC臨床數據密集兑現，創新藥板塊震盪回升算力需求預期遭重估

港股收評：恒指、國指終結5連跌！生物醫藥股狂歡，存儲芯片股承壓

艾普司韋破冰！AI製藥從概念照進現實，資本市場有何傾向？

港股收評：恒指漲0.45% 科指跌0.06% 創新藥概念股大漲存儲概念股下挫

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BK1574/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":482.35672,"timestamp":1789546124622,"preClose":496.71994,"halted":0,"volume":78292841,"delay":0,"changeRate":-0.028916,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":-14.36322,"latestTime":"09-16 16:00:00","open":496.59045,"high":497.2955,"low":481.3899,"amount":2159910416.1,"amplitude":0.032021,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789608600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"pbRate":3.69899,"peRate":164.598608,"turnoverRate":0.002939,"increases":11,"decrements":18,"flats":3,"marketCap":306781682880,"floatMarketCap":272645614616},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":497.2955,"amplitude":0.032021,"preClose":496.71994,"low":481.3899,"pbRate":"3.69899","latestPrice":482.35672,"volume":78292841,"delay":0,"open":496.59045,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":512.388,"twentyDayClose":492.831,"sixtyDayClose":437.952,"secType":"PLATE","market":"HK","turnoverRate":0.002939,"peRate":164.598608,"marketCap":306781682880,"floatMarketCap":272645614616,"timestamp":1789546124622,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":12,"down":18,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667466104","title":"CRO板塊強勢走高！多家CRO上市公司解密業務近況","url":"https://stock-news.laohu8.com/highlight/detail?id=2667466104","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667466104?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 21:08","pubTimestamp":1789391280,"startTime":"0","endTime":"0","summary":"在互动平台与机构调研中，多家具备CRO业务的上市公司近期密集回应市场关切，披露了订单、产能及全球化布局的最新进展。2026 年上半年，公司实现 CRO 销售收入 4,513.95 万元， 较上年同期增长 10.91%。截至 2026 年上半年末，客户群体不断扩大，累计服务超过 16,900 家研发实验室客户。CRO 业务毛利率基本保持相对稳定水平，具体受服务类型、项目内容影响有所波动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2026-09-14/doc-inirveaq9305051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4231","NETL","BK4080","BK1574","MEDX","ADC","IBBQ","06978","BK1161","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666143","title":"智通港股解盤 | 美國放緩AI另有玄機 WCLC大會再度催化創新藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666143","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666143?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 20:45","pubTimestamp":1789389921,"startTime":"0","endTime":"0","summary":"科技股的走弱，和 Anthropic、OpenAI 与 SpaceX 罕见联手集体呼吁放缓AI 开发步伐有关。业绩方面，多光谱 AI 大模型服务收入冲到 3.20 亿元，同比暴涨 382.5%，收入占比直接从 29.8% 飙升至 78%。机构认为，2026 年 WCLC 大会的主角仍是 IO2.0 与 ADC，肺癌领域尤其是 1L 非小细胞肺癌的标准治疗范式正处于迭代前夜，国产双抗与 ADC 的进度全球领先。授权品种的里程碑付款与商业化分成，正在成为创新药企业价值兑现的第二曲线。这是公司首款双抗 ADC 获批临床，也是公司第三款 ADC 创新药进入临床。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495830.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHAT","06978","LU0348735423.USD","01193","BK1566","IE00B543WZ88.USD","06160","LU0307460666.USD","02688","LU0593848301.USD","IE00BPRC5H50.USD","IE00BZ08YS42.EUR","VXUS","IE00BMCWC346.EUR","BK1521","AGIX","VTHR","LU0431992006.USD","LNGR","LU0651946864.USD","LU1051768304.USD","LU1515016050.SGD","MEDX","LU0877626530.USD","IE00BZ08YR35.GBP","159992","QTOC","BK1500","IE00BGHQDM52.EUR","ARTY","AIPO","KCAI","LU1969619763.USD","09969","BK1161","LU0640798160.USD","LU0821914370.USD","LU1808992512.USD","00135","IE0008369823.USD","IE00BZ08YT58.USD","BK4588","LU0287142896.SGD","LU1224709979.USD","KURE","IBBQ","06690","BK1574","IE00B29SXG58.USD","IE0034224299.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667719665","title":"心瑋醫療-B(06609)授出56萬份股份獎勵","url":"https://stock-news.laohu8.com/highlight/detail?id=2667719665","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667719665?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 20:23","pubTimestamp":1789388635,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B(06609)发布公告，于2026年9月14日，本公司根据本公司于2025年5月26日采纳并经不时修订的2025年H股激励计划(2025年H股激励计划)，向本集团雇员(承授人)授出56万份股份奖励(奖励)(2026年9月授出)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1100","BK1587","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667469668","title":"康寧傑瑞製藥-B(09966)9月14日耗資約79.63萬港元回購9.9萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667469668","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667469668?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:23","pubTimestamp":1789384984,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B(09966)公布，2026年9月14日耗资约79.63万港元回购9.9万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","09966","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663590","title":"董事會主席兼首席執行官倪昕增持億騰嘉和(06998)20萬股 每股作價約1.74港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663590","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663590?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:10","pubTimestamp":1789384234,"startTime":"0","endTime":"0","summary":"9月10日，董事会主席兼首席执行官倪昕增持亿腾嘉和(06998)20万股，每股作价1.7445港元，总金额约为34.89万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260914/20260914191110_45297.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260914/20260914191110_45297.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495799.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["EWH","BK1583","BK1161","06998","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668966","title":"縮量震盪下，創新藥逆市爆發，中證銀行指數上探年內新高！光模塊回調，高「光」ETF獲資金逢低關注","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668966","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668966?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:10","pubTimestamp":1789384200,"startTime":"0","endTime":"0","summary":"AI硬件赛道普遍回调，受硅谷“降速”言论影响，光模块龙头承压明显，高“光”创业板人工智能ETF华宝标的指数收跌2%，资金逢低关注布局机会。分红方面，国有六大行2026年度中期现金分红总额拟超2000亿元，同时为进一步增强投资者的获得感，均将中期拟分红比例由30%提高至31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-14/doc-iniruxuu7290017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK1161","LNGR","159253","BK4588","AAOZ","BK1574","FDN","IBBQ","BK4550","LUMA","LYTE","AAOX","399986","AAOG","159992","MEDX","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667063","title":"董事會主席吳以芳增持雲頂新耀(01952)8000股 每股作價26.9港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667063","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667063?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:08","pubTimestamp":1789384113,"startTime":"0","endTime":"0","summary":"9月11日，董事会主席吴以芳增持云顶新耀(01952)8000股，每股作价26.9港元，总金额为21.52万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260914/20260914190902_80115.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260914/20260914190902_80115.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495795.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","EWH","BK1161","01952","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668325","title":"德琪醫藥-B(06996.HK)因受限制股份單位獲歸屬而發行合共1009萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668325","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668325?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:07","pubTimestamp":1789384054,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","06996","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667670666","title":"董事長兼總裁吳豫生增持同源康醫藥-B(02410)17萬股 每股作價約2.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667670666","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667670666?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:07","pubTimestamp":1789384024,"startTime":"0","endTime":"0","summary":"9月11日，董事长兼总裁吴豫生增持同源康医药-B(02410)17万股，每股作价2.7036港元，总金额约为45.96万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260914/20260914190726_24966.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260914/20260914190726_24966.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["159938","EWH","BK1515","02410","09939","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667685646","title":"ETF日報：短期看在A股整體市場動能偏弱、熱點輪動加快的環境下，前期調整的創新藥、CXO板塊擁有一定性價比","url":"https://stock-news.laohu8.com/highlight/detail?id=2667685646","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667685646?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:02","pubTimestamp":1789383720,"startTime":"0","endTime":"0","summary":"形成赛道级利好共振，重塑市场对创新药研发进度与商业化价值的预期，修复创新药β行情，抬升CXO产业链订单与研发景气度预期。前期创新药、CXO板块经历持续回调，整体估值与市场情绪充分降温，板块点位回落至6-8月宽幅震荡箱体下沿位置，具备一定的技术性反弹空间。展望后市，短期看，在A股整体市场动能偏弱、热点轮动加快、反弹逐步收敛的环境下，前期调整的创新药、CXO板块拥有一定性价比。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-14/doc-iniruxuw4057482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","83130","159992","02827","06978","02846","BK4550","159982","FDN","03188","399300","03130","IBBQ","BK1574","07233","BK1147","BK1161","MEDX","WX","CXO","LNGR","82846","BK4585","83188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657414","title":"康哲藥業(00867)：創新藥高選擇性TYK2抑制劑CMS-D001 獲得系統性紅斑狼瘡適應症藥物臨床試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657414","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657414?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:23","pubTimestamp":1789381419,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 公布，于2026年9月11日，创新药CMS-D001片获得中国国家药品监督管理局签发的药物临床试验批准通知书，于2026年9月14日收到药物临床试验批准通知书。NMPA同意集团开展临床试验以评价CMS-D001治疗系统性红斑狼疮适应症的有效性和安全性。CMS-D001作为高选择性TYK2抑制剂，相较于泛JAK抑制剂，CMS-D001对其他JAK家族激酶的影响较小，可在长期疾病控制中维持疗效并降低相关安全风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BYV24P56.USD","IE00BVYPNQ40.USD","BMED","SG9999004311.SGD","PSYK","BK1161","LNGR","IBBJ","SG9999015986.USD","LU2488822045.USD","159992","00867","06978","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999015952.SGD","BK1574","BK1593","IE00BVYPNP33.GBP","IBBQ","MEDX","BK1191","SG9999004220.SGD","IE00BGHQDM52.EUR","SG9999015978.USD","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983650","title":"國家醫保局公布價格招採信用評價「特別嚴重失信」和「嚴重失信」名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983650","media":"央视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983650?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:00","pubTimestamp":1789380000,"startTime":"0","endTime":"0","summary":"受国家医疗保障局委托，国家医疗保障局医药价格和招标采购指导中心汇总了截至2026年7月1日各省份评级为“特别严重失信”和“严重失信”的医药企业情况，现公告如下。注3：价格招采信用评级主要依据行贿金额、不正当价格行为、扰乱集中采购秩序等严重程度进行确定。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-14/doc-iniruxuu7272468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1161","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657738","title":"恒瑞創新藥凝血因子XI單抗SHR-2004注射液用於擇期膝關節置換手術後成年患者靜脈血栓預防的上市申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657738","media":"恒瑞医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657738?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:59","pubTimestamp":1789379940,"startTime":"0","endTime":"0","summary":"近日，恒瑞医药子公司北京盛迪医药有限公司收到国家药监局下发的《受理通知书》，公司1类创新药、凝血因子XI单克隆抗体SHR-2004注射液的药品上市许可申请获受理，拟定适应症为：用于择期膝关节置换手术的成年患者，以预防静脉血栓形成。该研究旨在评价行择期TKA的患者使用SHR-2004注射液预防静脉血栓栓塞症的有效性和安全性。此外，SHR-2004用于卵巢癌术后VTE预防的Ⅱ期试验已完成。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-14/doc-iniruxuy4531842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","LNGR","159992","IPOS","06978","MEDX","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667652997","title":"北水動向|北水成交淨買入44.71億 北水逢低加倉AI硬件股 全天搶籌智譜(02513)超12億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667652997","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667652997?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:46","pubTimestamp":1789379185,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，9月14日港股市场，北水成交净买入44.71亿港元。北水净买入最多的个股是智谱、长飞光纤光缆、联想集团。港股通(沪)活跃成交股港股通(深)活跃成交股智谱获净买入12.01亿港元。浙商证券指出，该事件短期使AI硬件公司，大模型公司承压。康方生物、药明生物分别获净买入1.04亿、1385万港元。随新旗舰产品推出，该行认为小米收入及盈利应于2026年第三季见底，并于第四季开始反弹。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0128525689.USD","80992","LU0049112450.USD","LU0052756011.USD","LU0264606111.USD","LU0672654166.SGD","LU1961090484.USD","BK1506","AIPO","CHAT","LU0417516738.SGD","SG9999006597.SGD","BK1193","LU0048580855.USD","KURE","LU0561508036.HKD","02513","TCHI","LU0307460666.USD","BK1117","HK0000306685.HKD","HK0000320223.HKD","LU1206782309.USD","AGIX","LU0862451837.USD","LU0348735423.USD","00992","LU0634319403.HKD","LU0588546209.SGD","LU0972618739.USD","BK1574","IE00B0JY6N72.USD","LU1785774172.SGD","LU0310800965.SGD","IE00BPRC5H50.USD","LNVGY","06869","VTHR","ARTY","LU0890818403.SGD","QTOC","IE0034224299.USD","LU0348825331.USD","09926","LU1046422090.SGD","LU0029875118.USD","HK0000320264.USD","BK1161","HK0000306701.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667542416","title":"歸創通橋(02190)9月14日斥資113.14萬港元回購5.5萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667542416","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667542416?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:36","pubTimestamp":1789378589,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，该公司于2026年9月14日斥资113.14万港元回购5.5万股股份，每股回购价格为20.2-20.72港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495699.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02190","BK1583","BK1100","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667654038","title":"市場縮量調整，三大指數震盪回調，醫藥銀行集體護盤| 華寶基金3A日報（2026.9.14）","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654038","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667654038?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:30","pubTimestamp":1789378200,"startTime":"0","endTime":"0","summary":"MACD金叉信号形成，这些股涨势不错！","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-14/doc-inirutpa4636245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1574","BK1161","161121","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667582651","title":"ETF日報(09.14)丨WCLC臨床數據密集兑現，創新藥板塊震盪回升 算力需求預期遭重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2667582651","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667582651?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:44","pubTimestamp":1789375451,"startTime":"0","endTime":"0","summary":"WCLC临床数据密集兑现，创新药板块震荡回升；AI巨头集体\"喊停\"，算力需求预期遭重估，通信板块多数走低。行业表现WCLC临床数据密集兑现，国内外投行相继看好中国CRO/CDMO复苏明确，创新药板块震荡回升。消息面上，9月12日至15日，2026年世界肺癌大会在韩国首尔举行，多项国产创新药临床数据集中亮相，中国新药入选口头报告19项、小型口头报告45项，双双刷新历史纪录，肺癌领域ADC与双抗数据成为焦点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","LNGR","MEDX","FDN","06978","BK4585","BK4550","EPAI","AIVC","BAI","159992","BK1161","AIQD","AIQU","IBBQ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659490","title":"港股收評：恒指、國指終結5連跌！生物醫藥股狂歡，存儲芯片股承壓","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659490","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659490?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:35","pubTimestamp":1789374958,"startTime":"0","endTime":"0","summary":"南向资金净买入44.71亿港元","market":"sg","thumbnail":"https://img3.gelonghui.com/442f4-225f5f62-62e8-4a54-8c80-004f29e3b51c.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/442f4-225f5f62-62e8-4a54-8c80-004f29e3b51c.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6643045","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0417516902.SGD","LU1048588211.SGD","SG9999014674.SGD","LU0762540952.USD","LU0856984785.SGD","83115","07200","07552","BK1615","IE0034224299.USD","03037","LU0456827905.SGD","HK0000306701.USD","LU0831093199.SGD","LU1188198961.HKD","03115","LU0228367735.SGD","LU1328615791.USD","BK1095","513600","LU0197773673.USD","LU0052750758.USD","BK1574","LU0315179316.USD","BIDU","LU1206782309.USD","LU0039217434.USD","LU2476274308.USD","LU0051755006.USD","LU1481107354.HKD","HK0000320264.USD","02802","09969","03423","LU0640798160.USD","LU0149721374.USD","HSTECH","LU0630378692.HKD","09067","HK0000306685.HKD","03033","03419","TCHI","LU1831875114.USD","LU0823426480.USD","BK1575","BK1587","LU0348735423.USD","03416","LU0348825331.USD","LU0229945570.USD","LU0173614495.USD","IE00B3M56506.USD","02828","LU1048596156.SGD","89888","LU0320764599.SGD","LU0417516738.SGD","BK1588","LU0072462343.USD","09088","SG9999002463.SGD","LU0871576103.HKD","02837","BK1161","LU0708995583.HKD","HSCEI","HHImain","LU1023057109.AUD","LU0630378429.USD","09888","LU0043850808.USD","LU0823426308.USD","07300","LU0244354667.USD","LU0463099449.HKD","LU1115378108.SGD","LU0307460666.USD","03088","02800","HK0000320223.HKD","BK1609","HSI","LU0163747925.USD","LU0164865239.USD","07226","LU0531971595.HKD","LU2778985437.USD","07500","LU0588546209.SGD","SG9999002828.SGD","03032","82800","LU0543330566.HKD","LU2039709279.SGD","02833","LU0762541174.USD","LU0287142896.SGD","LU0359202008.SGD","MCHmain","LU0821914370.USD","LU0197773160.USD","03417","09115","03067","LU0819121731.USD","LU0359201612.USD","07288","LU0326950275.SGD","82828","688428","07588","LU0164880469.USD","LU0359201885.HKD","LU0762542818.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667665143","title":"艾普司韋破冰！AI製藥從概念照進現實，資本市場有何傾向？","url":"https://stock-news.laohu8.com/highlight/detail?id=2667665143","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667665143?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:30","pubTimestamp":1789374601,"startTime":"0","endTime":"0","summary":"日前，国内首款AI辅助研发的原创药艾普司韦获批上市。比如，艾普司韦，从源头发现到完成临床试验，仅用时三年半。而艾普司韦的研发过程，充分展现了AI技术对新药研发的颠覆性赋能。三重核心共振实际上，国内AI制药已从早期的概念探索、技术试错阶段，正式迈入商业化落地爆发期。除艾普司韦外，国内多家药企、科创企业布局的AI辅助研发新药已进入临床试验阶段，覆盖抗感染、抗肿瘤、慢性病、罕见病等多个热门领域。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/14/20260914530026.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/14/20260914530026.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260914/32369044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1191","VTHR","ARTY","CHAT","BK1574","AIPO","AGIX","QTOC","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667593836","title":"港股收評：恒指漲0.45% 科指跌0.06% 創新藥概念股大漲 存儲概念股下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2667593836","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667593836?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:08","pubTimestamp":1789373280,"startTime":"0","endTime":"0","summary":"截至收盘，恒生指数涨0.45%，报24917.60，恒生科技指数跌0.06%，国企指数涨0.46%。盘面上，科网股涨跌不一，快手跌超2%，阿里跌超1%，小米涨超3%，联想涨超2%；创新药概念股大涨，诺诚健华涨超14%；汽车股活跃，北京汽车涨超17%；存储概念股跌幅居前，江波龙跌超9%。创新药概念股大涨，诺诚健华涨超14%。广汽集团A股因“重要事项未公告”于9月14日全天紧急停牌。存储概念股跌幅居前，江波龙跌超9%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-14/doc-inirutny4042987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4505","BK4533","03037","01958","LU0918141887.USD","BK1119","LU0039217434.USD","BK4588","LU1688375341.USD","07200","BK1575","LU1366334578.USD","LU0072462343.USD","07226","LU1235295612.USD","BK1583","82800","LU0048580855.USD","01951","LU0106959298.USD","513600","LU1366334651.USD","LU1880383440.USD","LU2778985437.USD","LU1303224171.USD","LU2294711473.HKD","BABU","LU0791591158.USD","ONLN","LU0823426308.USD","LU1008478684.HKD","BK1539","LU0605514214.HKD","BK4503","LU0791590937.USD","LU0540923850.HKD","LU0588546209.SGD","LU1769817179.HKD","LU1813983027.USD","BBYY","LU1823568750.SGD","BK1161","LU1868838027.USD","02837","IE00BF5LJ272.USD","LU0254981946.USD","LU0348766576.USD","LU0821914370.USD","BK4579","09969","LU1719994722.HKD","81810","BK1193","03033","BK4554","LU0047713382.USD","LU1152091168.USD","LU0545039389.USD","LU0143863198.USD","BK4527","LU0264606111.USD","LU2257852520.SGD","BK1610","LU2097828631.EUR","LU0049112450.USD","03067","LU0084288322.USD","BK1219","LU0345775950.USD","LU2039709279.SGD","BK4581","LU0463099449.HKD","LU0326950275.SGD","LU0449515922.USD","BK1502","LU0531971595.HKD","LU0128522157.USD","LU1769817096.USD","BK4585","LU0417516738.SGD","LU0972618739.USD","LU1046422090.SGD","LU0456846285.SGD","LU0651946864.USD","LU0235996351.USD","LU0572944931.SGD","07552","LU0359201612.USD","LU0348816934.USD","LU1770036033.HKD","LU1051769294.HKD","BK1591","LU0348735423.USD","LU0499858438.USD","02238","LU0543330483.HKD","LU0672654166.SGD","BK4531","LU0251143458.SGD","LU0823413587.USD","LU1808992512.USD","LU0823038988.USD","HK0000306701.USD","LU1023057109.AUD","KSTmain","LU0634319403.HKD","09088","03423","SOCL","LU2148611432.USD","LU1720050803.USD","LU0572940350.SGD","SG9999003461.SGD","BK4526","LU0949170772.SGD","LU0651947912.USD","LU2097828805.USD","LU0128525689.USD","LU0370786039.SGD","LU0149721374.USD","BK1608","LU0553294199.USD","LU1481107354.HKD","LU0348825331.USD","LU1961090484.USD","LU0169518387.USD","LU2087589342.USD","DRAG","03419","LNVGY","LU0449509016.USD","HK0000165453.HKD","LU0320764755.SGD","LU1956131251.USD","BK4535","01024","LU0307460666.USD","HK0000320223.HKD","LU0210526637.USD","LU0067412154.USD","LU0417516902.SGD","LU0531970944.HKD","LU1152091754.HKD","LU0327786744.USD","IE00B0JY6N72.USD","BK4614","LU1242518931.SGD","LU1328277881.USD","LU1242518857.USD","LU0348814723.USD","LU0164872284.USD","LU1282648689.USD","LU0348767384.USD","LU0650527681.SGD","BK4543","XIACY","02833","03417","LU0661504455.SGD","LU0862451753.SGD","LU0029875118.USD","BK4565","LU0051755006.USD","HHImain","LU0054450605.USD","LU0320764599.SGD","LU1770034418.SGD","DRGN","TCHI","LU0456842615.SGD","LU0328353924.USD","BK1095","BK4502","LU0072913022.USD","LU0164865239.USD","LU0499858602.USD","BK1523","HK0000320264.USD","LU2097828557.USD","BABX","09067","LU0594300419.USD","MCHmain","LU0572939691.SGD","LU0880133367.SGD","LU2226246903.HKD","07300","BK4122","BK4220","80992","LU0593848301.USD","LU0675040207.SGD","SG9999001093.SGD","81024","LU1981816686.USD","LU0140636845.USD","83115","LU1048596156.SGD","IE00B3M56506.USD","LU0052750758.USD","HSI","ALBmain","LU0823039010.USD","LU1868837565.USD","LU0890818403.SGD","LU1048588211.SGD","IE0003895053.USD","09988","IE00BFMHRM44.USD","LU0214875030.USD","02800","LU1105468828.SGD","00992","LU1794554557.SGD","LU0310800965.SGD","LU0823413660.USD","LU0823041008.USD","CLIX","BABW","01810","601238","LU0708995583.HKD","HXXD.SI","03032","LU0211977185.USD","KBAB","LU2476274720.SGD","03088","09115","MIUmain","IE0034224299.USD","LU2097828714.EUR","BK1589","BK1597","LU1267930227.SGD","BK4587","LU1003077747.HKD","LU0143863784.USD","BABO","LU0345776255.USD","LU2097828474.EUR","LU0823426480.USD","LU1235294995.USD","LU0052756011.USD","HSTECH","07500","LU0738911758.USD","LU0918141705.HKD","LU0164880469.USD","LU2152927971.USD","LU1880383366.USD","LU0862451837.USD","LU0823397285.USD","LU0979878070.USD","BK4607","LU0244354667.USD","BK1590","LU0700851271.USD","LU0594300179.USD","LU0359202008.SGD","BK4534","LU0871576103.HKD","BK4524","BK1607","BK1506","BK4558","LU2242644610.SGD","LU2476274308.USD","BK1521","BK4575","LU0611395673.USD","LU1046421795.USD","SG9999002463.SGD","LU0359201885.HKD","BK1574","IE0032431581.USD","LU0823040885.USD","LU1323998911.USD","LU1251922891.USD","BK1526","LU0348827113.USD","HK0000306685.HKD","BK1618","LU0823397103.USD","BK1615","BABC","LU0441854154.USD","LU1515016050.SGD","LU0231483743.USD","LU0314109678.HKD","LU0797268264.HKD","LU1051768304.USD","LU1188198961.HKD","BABA","BK4504","LU0117841782.USD","688428","BK4548","LU0501845795.SGD","LU2399975544.HKD","HK0000286598.CNH","LU0561508036.HKD","BK4538","LU1785774172.SGD","LU0456827905.SGD","03115"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":3,"totalSize":335,"code":"91000000","status":"200"}]}}